Clinical Trials Directory

Trials / Unknown

UnknownNCT01677351

Assessment of the Effect of Clonidine for Cataract Surgery

Assessment of the Effect of Clonidine on Pain, Arterial and Intraocular Pressure and Arrhythmias for Cataract Surgery

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Clonidine, an agonist for alfa2 pre-synaptic, has been shown to be an effective adjuvant therapy for acute postoperative pain and has been shown an effect in sedative, intra-ocular and blood pressure and arrhythmias.The objective of this study is evaluating the analgesic effect of clonidine and its repercussion on arterial and intraocular pressure and arrhythmias for cataract surgery.

Detailed description

After approved by the Ethical Committee and signed informed consent, 40 patients aged from 40 until 80 years undergoing cataract extraction will be randomized in two groups. Exclusion criteria will be myocardial ischemia, psychiatric disease, chronic pain, drugs dependency, chronic use of beta-blockage channel drugs. Group 2, patients will receive a single dose of 4mcg.kg-1 of clonidin2, 20 minutes before the surgical incision; group 1, patients will receive a sterile saline solution dose. Pain intensity will be assessed with the numeric rating scale. The antiarrythmic effect will be assessed with the continuous measure by Holter. The number of patients was calculated by Instat Graph® program. To detect difference in pain intensity of 3 between the groups by NRS, with 95% of power (estimated SD= 2.0), when the alpha level is set at 0.05, the sample should be of 20. Statistical analyses will be performed with parametric and nonparametric tests, considering the variety studied. The statistical program that will be utilized is Instat Graph®.

Conditions

Interventions

TypeNameDescription
DRUGClonidine4 mcg.kg-1, 20 minutes before cataract surgery
DRUGplacebo

Timeline

Start date
2011-07-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2012-09-03
Last updated
2012-09-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01677351. Inclusion in this directory is not an endorsement.